Sort by
Keyphrases
3-stage
16%
Adult Mice
16%
Angiogenesis Inhibitors
16%
Arteriovenous
16%
Conditional Model
16%
DC101
16%
Developmental Stages
33%
Disease Model
16%
DNA Damage Checkpoint
16%
Endothelial Proliferation
16%
H2AX
16%
Hypoxia-inducible factor-1α (HIF-1α)
100%
Illness
16%
Immuno
33%
Inhibitor Resistance
16%
Intrinsic Mechanism
16%
Label-free
16%
Maintenance Stage
16%
Microscopic Analysis
16%
Microvascular Architecture
16%
Microvessels
50%
Morphogenesis
16%
Myeloid Cells
100%
Neovascularization
100%
Neovasculature
16%
Non-cell Autonomous
16%
Pericyte Coverage
16%
Photoacoustic Microscopy
50%
Red Blood
16%
Serial Imaging
16%
Tight
16%
Tumor Growth
16%
Tumor Ischemia
16%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
33%
Vasculature
16%
VEGF Inhibitors
100%
VEGFR-2 Inhibitors
16%
Volumetric Change
16%
Medicine and Dentistry
Angiogenesis Inhibitor
33%
Developmental Stage
66%
Disease Model
33%
Diseases
100%
DNA Damage Checkpoint
33%
Downregulation
33%
Immunoglobulin
66%
Ischemia
33%
Microvessel
100%
Monoclonal Antibody DC101
33%
Morphogenesis
33%
Myeloid Cell
100%
P21
33%
Pericyte
33%
Photoacoustic Microscopy
100%
Protein P53
33%
Transgene
33%
Tumor Progression
33%
Vascularity
33%
Immunology and Microbiology
Angiogenesis Inhibitor
20%
Developmental Stage
40%
DNA Damage Checkpoint
20%
Downregulation
20%
Intravenous Immunoglobulin
40%
Monoclonal Antibody DC101
20%
Morphogenesis
20%
Myeloid
100%
Neovascularization (Pathology)
100%
P53
20%
Pericyte
20%
Transgene
20%
Vascularization
20%